eptifibatide .75 mg/mL
eptifibatide · INJECTION, SOLUTION · Sagent Pharmaceuticals
No Recall History
Plain English
eptifibatide is a injection, solution containing eptifibatide at .75 mg/mL, taken intravenous. Manufactured by Sagent Pharmaceuticals.
Key Facts
- Brand Name
- eptifibatide
- Generic Name
- eptifibatide
- NDC Code (Product)
25021-408- Manufacturer
- Sagent Pharmaceuticals
- Strength
- .75 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA204693
- Drug Class
- Platelet Aggregation Inhibitor [EPC]
- Marketing Start
- 07/15/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is eptifibatide used for?
eptifibatide contains eptifibatide. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is eptifibatide a controlled substance?
eptifibatide is not classified as a controlled substance by the DEA.
What is the generic name for eptifibatide?
The generic name for eptifibatide is eptifibatide. There are 11 other brand versions of eptifibatide.
What is the NDC code for eptifibatide .75 mg/mL?
The NDC (National Drug Code) for eptifibatide .75 mg/mL is 25021-408, listed by Sagent Pharmaceuticals.